|
 |
| |
| |
| About Ripare™ : |
|
| Osteoporosis, a condition characterized by reduction in bone density, is prevalent among postmenopausal women and manifest clinically as fragility fractures. RIPARE a safe poltherbal formulation reduces bone resorption & prevents bone loss, thereby reducing the risk of pathological fractures considerably. |
|
|
|
|
|
